Ten year outcomes of participants in the REACT (Randomised Evaluation of Assertive Community Treatment in North London) study by unknown
Killaspy et al. BMC Psychiatry 2014, 14:296
http://www.biomedcentral.com/1471-244X/14/296RESEARCH ARTICLE Open AccessTen year outcomes of participants in the REACT
(Randomised Evaluation of Assertive Community
Treatment in North London) study
Helen Killaspy1*, Laia Mas-Expósito2, Louise Marston3,4 and Michael King1,4Abstract
Background: A previous randomised controlled trial that investigated Assertive Community Treatment (ACT) in the
UK (the REACT Study) found no clinical advantage over usual care delivered by Community Mental Health Teams
(CMHTs) at 18 and 36 month follow-ups. No studies have investigated long term clinical and social outcomes for
patients receiving ACT.
Method: We investigated inpatient service use, social outcomes, service contact and adverse events for the 251
REACT study participants 10 years after randomisation through case note review. Data were analysed using
regression models adjusted for original treatment group allocation and changes in treatment group.
Results: We found no statistically significant differences in outcomes by original treatment group over the 10 years.
Those whose care remained with ACT, or transferred to ACT or forensic services, had more inpatient days over the
10 years (coefficient 223, 95% CI 83 to 363, p = 0.002) than those whose care remained with the CMHTs or were
discharged to primary care. Being subject to a Community Treatment Order was associated with a greater chance
of being under ACT at 10 year follow-up (OR 6.39, 95% CI 2.98 to 13.70, p <0.001).
Conclusions: The ACT teams in this study showed no clinical advantage over usual care provided by CMHTs at
10 year follow-up. We also found that the ACT teams accrued patients from the original study sample who had
more complex needs than those who remained with or transferred to the CMHTs or primary care during this
period. Further well conducted trials are needed to identify the most cost-effective approaches to supporting
successful community living and optimum long term outcomes for this group.
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Assertive Community Treatment (ACT) teams were im-
plemented across England from 1999 onwards as part of
the National Service Framework for Mental Health [1].
These teams provide flexible and intensive, home based
support to people with severe mental health problems
who are high users of inpatient care and have problems
engaging with standard mental health services [2]. There
is good evidence for their clinical efficacy when compared
against standard outpatient care in terms of reducing
the need for inpatient care and associated costs [3].* Correspondence: h.killaspy@ucl.ac.uk
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unless otherwise stated.However, these advantages have not been replicated
where “standard” care delivers a more intensive form of
case management that replicates some of the key com-
ponents of ACT [3-5]. However, meta-analysis of trials
of intensive case management have concluded that the
clinical benefits (particularly reduced inpatient service
use) are most evident where there is higher fidelity to
the ACT model and higher use of inpatient care in the
local population [3,4]. The Randomised Evaluation of
Assertive Community Treatment in North London
(REACT) study assessed outcomes for 251 people ran-
domly assigned to receive either ACT or standard case
management from community mental health teams
(CMHTs). Eighteen months after randomisation, no
clinical advantage for ACT was found in terms ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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satisfied and better engaged with services [5]. A
further follow-up 18 months after the trial ended (at
36 months) replicated these main results, though by
then 20 of the original ACT and 20 original CMHT
participants had changed study arms [6]. Selection
criteria for participants in the REACT study included
high use of inpatient care and the comparison CMHTs
had high fidelity for only one of the key ACT compo-
nents (offering a time unlimited service).
Given that we had previously found no difference in
inpatient service use between participants receiving ACT
and comparison CMHT services at 18 and 36 month
follow-up, the wisdom of further follow-up could be
questioned. However, no studies of ACT have investigated
outcomes beyond 36 months and it is not known whether
receipt of this more intensive support might lay founda-
tions for a better life course and less need for inpatient
services, with benefits being manifest some years later.
Furthermore, the most recent Cochrane review of inten-
sive case management advised that studies of ACT should
also assess specific social outcomes (such as employment)
rather than assessing social function using standardised
measures [3].
The aim of this study was to investigate whether ACT
was associated with better long term clinical and social
outcomes and the predictors of ongoing need for ACT.
We therefore investigated inpatient service use and
social outcomes for participants in the REACT study
10 years after randomisation. We expected that many
participants would have changed from their original
treatment allocation by this point and that this would
need to be accounted for in our analysis. Although the
teams did not use any standardised criteria for transfers,
in order for an ACT patient to be accepted by a CMHT
(that provides less intensive support than the ACT teams)
or discharged to primary care, we felt it reasonable to
assume that they would have stabilised (be better engaged
and causing less concern to the ACT team). Similarly,
patients who transferred from a CMHT to the ACT team
were likely to be those where there were ongoing difficul-
ties in engagement, concerns about risk and recurrent
admissions to hospital. We were also aware that some
patients would have been transferred to forensic services
due to the severity of these issues. A transfer of care vari-
able reflecting this was therefore included in our statistical
models. We also investigated predictors of remaining in
ACT or being transferred to forensic services at 10 year
follow-up in order to identify factors associated with
ongoing use of these more intensive services.
The original REACT study and the further follow-up
studies were approved by the Camden & Islington
Community and Royal Free Hospital Research Ethics
Committee (Ref. 99/93).Method
The REACT study was carried out with full adherence to
CONSORT guidelines for the management of randomised
controlled trials. The methods and results 18 months after
randomisation have been reported elsewhere [7]. In brief,
the 251 participants were recruited from all CMHTs in
the London boroughs of Camden and Islington between
July 1999 and July 2002. They were high users of inpatient
care (at least 100 consecutive inpatient days or at least five
admissions within the past two years; or at least 50
consecutive inpatient days or at least three admissions
within the past year) who were living independently
and whom the CMHTs had found problematic to engage
over at least the previous 12 months. There were no
differences between the two groups in clinical or social
functioning at baseline.
Since including only consenting participants would
render the results irrelevant to the service users most
likely to be referred for ACT, the Research Ethics Com-
mittee approved randomisation and collection of case
note and key informant data on all participants, whether
or not they agreed to participate in the research inter-
views. Participants were randomly allocated on an equal
basis to the care of one of the two local ACT teams or
to continue with their CMHT. The fidelity of the ACT
teams was independently assessed using the Dartmouth
Assertive Community Treatment Scale [8] during the
REACT study and found to be high for one team, “ACT
like” for the other [7] and low for the CMHTs [9].
LME (co-author) collected data on participants’ contact
with services, inpatient service use, use of the Mental
Health Act and adverse events (deaths, incidents of self-
harm, violence, imprisonment, homelessness and loss of
contact with services) over the 10 years since randomisa-
tion. Details of employment/other occupation (supported
employment/courses) and use of supported accommoda-
tion over the 10 years were also gathered as well as their
current involvement in social/leisure activities and contact
with family. Data were collected from paper and electronic
case notes (implemented across the local mental health
services in 2006) except for three participants who had
moved out of the area and four participants whose care
had been transferred to forensic mental health services.
These participants’ data were gathered from their care
co-ordinators by email or telephone. For a further two
participants, no follow-up data could be collected as
both paper and electronic records were missing.
Participant flows
The original REACT study required 250 participants to
detect a difference of 60 (SD 169) bed days between the
ACT and CMHT groups with 80% power. Of 251 study
participants recruited, 127 were allocated to ACT and
124 to CMHT care. Eighteen months after randomisation,
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CMHT participant had emigrated, so primary outcome
data for the original trial were available for 124 ACT and
119 CMHT participants. Ten years after randomisation, a
further 17 ACT and 13 CMHT participants had died and
8 ACT and 2 CMHT participants had emigrated or Cere
out of contact with mental health services. Hence 10 year
outcome data were available for 99 ACT and 104 CMHT
participants. Forty-three of the original ACT participants
had been transferred back to the care of a CMHT, 4 had
been transferred to forensic services and 8 had been
discharged to primary care between the 18 month and
10 year follow-up. Of the CMHT participants, 23 had
been transferred to an ACT team, 2 had been transferred
to forensic services and 17 had been discharged to primary
care during this period. See Figure 1 for further details.
Data analysis
Our first analysis investigated whether participants in
the REACT study who were randomised to receive ACTParticipants
N=
Assertive Community Treatment 
(ACT) 
N=127 
Died n= 20 
Emigrated n= 6 
Lost to follow-up n= 2 
10 year follow-up data available 
N=99 
During this 10 year period:  
•  37 remained with ACT 
throughout  
•  43 transferred to CMHT care 
between the 18 month and 10 
year follow-up points 
•  8 were discharged to primary 
care  
•  4 were transferred to forensic 
services  
•  4 were transferred to CMHT and 
then back to ACT
•  3 were transferred to CMHT in 
another area
Figure 1 REACT study participant flows 10 years after randomisation.required less inpatient care over the 10 year follow-up
period than those randomised to receive CMHT care.
The total number of inpatient days used over the 10 years
was compared using a generalised estimating equation
(GEE) that was able to account for the fact that partici-
pants who died or emigrated during the 10 years would
not have data available for collection at all follow-up time
points. The model included participants’ total inpatient
days used at 36 month and 10 year follow-up. Standard
errors were created using bootstrapping with 5000
replications. Variables entered into the model included
the original treatment allocation at recruitment into the
trial (ACT or CMHT), inpatient days prior to recruitment
into the trial (to control for those who were very high
users of inpatient care [ACT median 441 (IQR 222, 834);
CMHT median 445 (IQR 264, 773)], and a binary time
varying variable that took into account changes in partici-
pants’ treatment between the end of the trial at 18 month
follow-up and 10 year follow-up, as explained in the
background (0 = those who had remained in the CMHT, randomised 
251
Community Mental Health Team 
(CMHT) 
N=124 
Died n= 17 
Emigrated n= 3 
10 year follow-up data available 
N=104 
During this 10 year period:  
•  47 remained with CMHT 
throughout  
•  23 transferred to ACT care 
between the 18 month and 10 
year follow-up points 
•  19 were discharged to primary 
care  
•  2 were transferred to forensic 
services  
•  7 were transferred to ACT and 
then back to CMHT 
•  6 were transferred to CMHT in 
another area 
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ACT or CMHT to primary care; 1 = those who had
remained in ACT, transferred to ACT from primary care
or a CMHT or transferred to forensic services from an
ACT team or CMHT).Table 1 Ten year outcomes for REACT study participants by o
Outcome Assertive co
Inpatient service use Mean (SD)
Total inpatient days 1049 (1037)
Total admissions 6 (5)
Days per admission 236 (422)
Involuntary admissions 4 (4)
Admissions N
Any admission 99





Intensive Care Unit 99
Low Secure Unit 99
Medium Secure Unit 99
High Secure Unit 99
Supervised discharge* 93
Social outcomes N
Currently in employment or other occupation 99
Any employment or occupation 36 months to 10 years 99
Currently involved in social or leisure activities 81
Currently in contact with family 84
Currently living in supported accommodation 99
Any supported accommodation last 10 years 99
Adverse events N
Lost to follow-upa 83
Homelessness 99
Physical assault on another personb 99




Deliberate self-harm (DSH) 99
Recurrent DSHd 99
* Supervised discharge = Community Treatment Order or Section 25 of the Mental
aLost to follow-up defined as no face-to-face contacts between staff and clients in p
bThe victim could be known to the perpetrator or a stranger.
cThe most serious assault was one incident of manslaughter.
dRecurrent deliberate self-harm defined as at least five episodes in two years.We also investigated social outcomes at the 10 year
follow-up point (employed or in supported employment or
enrolled on an educational or vocational course; involved
in social and/or leisure activities; having contact with
family) using logistic regression. A variable for the treat-riginal treatment allocation
mmunity treatment Community mental health team
N = 99 N = 104
Median IQR Mean (SD) Median IQR
671 301, 1515 948 (950) 592 256, 1333
5 2, 8 5 (4) 5 2, 7
119 70, 286 215 (304) 124 64, 239
3 1, 6 4 (4) 4 2, 6
n (%) N n (%)
90 (91) 104 93 (89)
104
14 (14) 7 (7)
6 (6) 8 (8)
70 (71) 78 (75)
84 (85) 104 92 (88)
24 (24) 104 28 (27)
2 (2) 104 0 (0)
6 (6) 104 5 (5)
1 (1) 104 0 (0)
23 (25) 99 21 (21)
n (%) N n (%)
31 (31) 104 39 (38)
61 (62) 104 59 (57)
38 (47) 80 30 (38)
60 (71) 85 50 (59)
39 (39) 104 52 (50)
64 (65) 104 58 (56)
n (%) N n (%)
8 (10) 76 12 (16)
20 (20) 104 23 (22)
51 (52) 104 62 (60)c
26 (26) 104 22 (21)
11 (11) 104 20 (19)
12 (12) 103 13 (13)
19 (19) 104 29 (28)
23 (23) 104 30 (29)
8 (8) 104 7 (7)
Health Act (1983).
revious three months (this variable is not measured over the last 10 years).
Table 2 Linear regression with generalised estimated equation of total inpatient days used over the 10 years after
randomisation into REACT study
Coefficient Bootstrap SE 95% CI p
Randomised to ACT −34.61 51.16 (−179.30, 110.09) 0.639
Stayed with or transferred to ACT 223.01 71.38 (83.10, 362.92) 0.002
Inpatient days prior to randomisation 0.19 0.072 (0.05, 0.33) 0.009
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or primary care, 1 = ACT or forensic) was included in the
model along with a similar binary change of treatment
variable (as described above) to account for subsequent
transfers between services (time invariant, 36 months to
10 years). Transfers of care between 36 month and 10 year
follow-up were included rather than between 18 month
and 10 year follow-up because social outcome data were
only collected at 36 month and ten year follow-up. Due to
low numbers of people employed or engaged in social or
leisure activities at 10 year follow-up, these three variables
were combined.
Factors associated with being under the care of an ACT
team or forensic service at 10 year follow-up were also
investigated using logistic regression. Univariate analysis
was used to identify variables for inclusion in these models.Table 3 Logistic regression: social outcomes at 10 year
follow-up for participants of the REACT study
Odds ratio 95% CI p
Employed/course/social/leisure
ACT at 36 months 1.05 (0.53, 2.08) 0.88
Stayed with or transferred to
ACT (36 months to 10 years
after randomisation)
0.62 (0.31, 1.25) 0.18
Family contact
ACT at 36 months 1.65 (0.82, 3.32) 0.16
Stayed with or transferred to
ACT (36 months to 10 years
after randomisation)
1.10 (0.53, 2.26) 0.81Results
Descriptive data on all 10 year outcomes are shown in
Table 1 by original treatment allocation.
Our first analysis found that the initial randomisation
group (ACT or CMHT) was not statistically significantly
associated with total inpatient bed days over the 10 year
period (see Table 2). However, those whose care remained
with or transferred to ACT or forensic services during the
10 years (change variable group 1) used more inpatient
days on average than those whose care remained under
the CMHT, transferred from ACT to CMHT or were dis-
charged to primary care (change variable group 0). Having
been an inpatient for more days prior to randomisation
was also associated with a higher number of inpatient days
over the 10 years.
None of the social outcomes assessed at 10 year follow-
up were associated with treatment group at 36 months or
change in treatment group from 36 months to 10 years
(see Table 3).
Two factors were found to be associated with being in
ACT or forensic care at 10 years. Those randomised to
ACT originally were more likely to remain in ACT or be
in forensic care at 10 years than those allocated to CMHT
care originally (OR 2.89, 95% CI 1.49 to 5.60, p = 0.002).
Those who were on a Community Treatment Order
(CTO) at 10 year follow-up were more likely to be under
ACT or forensic care at this point than those who were
not on a CTO (OR 6.39, 95% CI 2.98 to 13.70, p < 0.001).Discussion and conclusions
We found no significant difference in 10 year outcomes for
participants of the REACT study. Our findings therefore
concurred with our previous results at 18 months and
36 months. After the original study ended, the ACT teams
continued to acquire patients from the original REACT
study sample who were allocated to CMHT care, whose
needs were complex (difficult to engage in treatment and
requiring recurrent admissions due to the severity of their
symptoms and risk profile) and to transfer or discharge
those who had stabilised. This probably explains why
inpatient bed use was higher for those who remained
with/transferred to ACT during the 10 years compared
to those who remained with/transferred to CMHT. This is
further supported by our finding that one of the two
factors associated with being under the ACT team at
10 years was being on a CTO. Alternatively, ACT teams
are perhaps more likely to admit their patients, to use
CTOs, and to refer them to forensic services than CMHTs.
However, given that the threshold for admission in inner
London is high and that the ACT teams do not hold
gatekeeping responsibility for admissions to inpatient
or forensic services, this seems unlikely (gatekeeping of
admissions to general inpatient services is the responsi-
bility of the local crisis resolution teams and admissions
to forensic services are usually directed by the criminal
justice system or agreed after assessment by a forensic
psychiatrist). It is however possible that the finding that
those randomised to ACT originally were more likely to
remain in ACT or be in forensic care at 10 year follow-up
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discharge clients who they had managed to engage with.
This study has an important limitation that needs to
be considered when interpreting the results. Data were
gathered from case notes and are therefore dependent
on the quality of recording of events by staff. However,
our data on inpatient service use are likely to be accurate
due to the considerable administrative infrastructure in
the NHS that primarily focuses on recording admission
and discharge data and the legal requirement for this for
detained patients. Since a very high proportion of patients
in this study were involuntarily admitted, it is reasonable
to assume that these data are robust. Similarly, the need
for clinicians to ensure accurate recording of risk inci-
dents means that our data on adverse events is also likely
to be reliable. However, the recording of information on
social outcomes is not subject to such close scrutiny and
it is therefore possible that these were not recorded as
accurately in the case notes. We may therefore have
underestimated social gains that patients made, though
we have no reason to suspect that this information would
have been recorded differently by ACT and CMHT staff.
A further limitation is that the study was carried out in
one area of North London and the results may therefore
not generalise to other settings and service contexts [10].
Our findings should not be interpreted as conclusive
evidence that ACT does or does not “work”, but they do
highlight the difficult task facing ACT teams and the
ongoing need for specialist services for people with se-
vere, longer term mental health problems. In keeping
with our original assumption, it appears that after the
trial ended, the ACT teams continuously accrued people
with complex psychosis; around one quarter of those
originally allocated to CMHT care required transfer to
ACT. In addition, around one third of those originally
allocated to ACT did not stabilise adequately for transfer
to CMHT or primary care. The ACT teams were also
taking on new clients who were not participants in the
original REACT study but who met the original criteria
(high users of inpatient care, with recurrent disengage-
ment from CMHT care). There is now considerable
disinvestment in ACT teams in England; many are
being disbanded or reconfigured into a more “dilute”
version of the ACT model which adheres less strictly
to ACT model fidelity and delivers fewer of the key
components [11]. Hybrid approaches that combine
features of ACT and standard case management are
popular in some European countries with similar mental
health systems to the UK [12] but no trials investigat-
ing their efficacy have been carried out to date. There
is ongoing international debate about whether ACT
should devolve back to a more generic case management
model in the UK [13-15]. What is certainly clear is that
investment in community teams that are adequatelyresourced to deliver evidence based treatment and
support to those with the most complex severe mental
health problems is required. Further well conducted
trials are needed to identify the most clinically effective
approaches that can support successful community
living and optimum long term outcomes for this group,
whether this is through traditional ACT or other models
of care.
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